Rashed Alhabshan
Retina Specialist · Corpus Christi, TXNPI 1811316680
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,995 of the $2,659 with a category attached, or 75.0%. 12 manufacturers reported payments, led by Mallinckrodt Enterprises LLC at 30.3% of the total. Reporting peaked in 2019 at $1,663 and has fallen 90.6% since, to $156 in 2025. That places this record below the midpoint for retina specialist clinicians in TX, where the typical reported total is $2,568.
Across 31 payments — averaging $85.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Enterprises LLC$805
- Bausch & Lomb, A Division Of Bausch Health US, LLC$427
- Regeneron$400
- Astellas Pharma US Inc$249
- Novartis$204
- Genentech USA, Inc.$203
- plus $371 from 6 others
What the payments were for
- Travel & lodging$66425%
- Food & beverage$1,99575%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,659 in reported general payments places this provider in the 50th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 19 | $924 |
| Timolol Maleate | 15 | $451 |
| Atropine Sulfate | 12 | $384 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $184 |
| Latanoprost | 17 | $176 |
| Brimonidine Tartrate | 17 | $84 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Corpus Christi
- Charles CampbellCorpus Christi$2K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.